Hargreaves clients suffer £400m hit from Woodford as execs enjoy bonuses
Total losses of £1.4bn in the LF Equity Income fund ‘cannot be put down to a Covid effect’
Link Fund Solutions
-
-
Former Woodford healthcare stock grateful to finally land new owner
Link Fund Solutions had held a 12% stake in Sensyne Health
-
Link receives first formal letter triggering litigation over Woodford debacle
ACD stands accused of allowing excessive investments in inappropriate assets
-
Link unveils third Woodford payment but remains coy on sale of remaining assets
Third distribution of £183m expected to be paid out among investors next week
-
Link faces fresh questions over timing of Neil Woodford firing
Sunday Times claims manager was making progress in de-risking the fund before being axed
-
Second law firm ‘actively considering’ case against Link in Woodford scandal
Slater and Gordon also says it now believes ‘there’s a case for Hargreaves to answer’
-
Link directors pocketed £2.7m in run up to Woodford fund suspension
Christopher Addenbrooke and Karl Midl also presided over Arch Cru and Connaught scandals
-
Link teases third payment to Woodford investors as Acacia proceeds drip through
ACD has £58m from sale of assets to Acacia but that value is set to increase over next three weeks
-
Woodford investors endure ‘another kick in the teeth’ as Synairgen quintuples
Biotech holding soars 550% one month after Link sold it on the cheap to Acacia Research
-
Juno Capital distances itself from Neil Woodford
Family office investing syndicate has been eyeing up assets held by the former equities manager
-
Link to replace part-time CIO that oversaw Woodford with full-time role
Eyebrows raised over the part-time nature of a role focused on investment risk
-
Acacia Research shrugs off ‘silly’ criticism after swiftly flipping Woodford assets
US buyer describes the low purchase price of Midatech as ‘a function of the tax and accounting treatment’
